FEATURES OF THE HEMOSTASIS SYSTEM IN INFANTS WITH ACUTE PNEUMONIA ON THE BACKGROUND OF PERINATAL CENTRAL NERVOUS SYSTEM INJURY
Abstract
Introduction. Acute pneumonia remains one of the leading causes of morbidity and mortality in early childhood. According to WHO data, approximately 15–18% of deaths among children under five years of age are due to lower respiratory tract infections. The course of pneumonia in infants with perinatal central nervous system (CNS) injury—resulting from hypoxia, ischemia, or perinatal asphyxia—is often severe and prolonged. These patients exhibit impaired immune responses, endothelial dysfunction, and disturbances in microcirculation, predisposing them to coagulation abnormalities. Therefore, assessment of the hemostatic system in this population is of critical clinical and prognostic importance. Objective. To evaluate the changes in hemostatic parameters among infants with acute pneumonia associated with perinatal CNS injury and to determine their relationship with disease severity and inflammatory activity. Materials and Methods. A comprehensive review and meta-analysis of 40 national and international studies published between 2015 and 2024 were conducted. Key parameters assessed included fibrinogen, D-dimer, APTT, PT, antithrombin III, protein C, and protein S levels. The concentrations of inflammatory cytokines (IL-6, TNF-α) were also evaluated. Statistical correlation and regression analyses were applied with a significance level of p < 0.05. Results. Infants with perinatal CNS injury demonstrated significant hemostatic imbalance characterized by hypercoagulation and impaired anticoagulant activity. Fibrinogen and D-dimer levels were increased by 1.5–2 times, while APTT and PT were shortened. Antithrombin III activity decreased by 25–30%. Elevated IL-6 and TNF-α levels showed strong positive correlations with D-dimer concentration (r = 0.62; p < 0.01), confirming the existence of a “coagulation–inflammation” feedback loop. Prophylactic anticoagulant therapy (microdose heparin, dipyridamole, pentoxifylline) significantly reduced thromboembolic complications (by 3–4 times) and accelerated clinical recovery and radiological resolution of pulmonary infiltrates. Discussion. These findings support that hemostatic disturbances constitute a fundamental pathophysiological mechanism in pneumonia associated with perinatal CNS injury. Hypercoagulability, endothelial injury, and suppressed fibrinolysis contribute to microcirculatory failure, tissue hypoxia, and prolonged inflammation. Conclusion. Regular monitoring of hemostatic markers (fibrinogen, D-dimer, antithrombin III) and inflammatory cytokines (IL-6, TNF-α) is essential for early detection of complications. Implementing timely anticoagulant therapy may improve outcomes, shorten recovery time, and reduce morbidity in infants with perinatal CNS injury.
Keywords:
About the Authors
List of references
Boskabadi H, Maamouri G, et al. Interleukin-6 as a prognostic biomarker in perinatal asphyxia. Iran J Child Neurol. 2021;15(3):45–54.
El Beshlawy A, et al. Protein C, S and antithrombin III levels in hypoxic neonates. Acta Haematol. 2004;111(3):182–187.
El-Beshlawy A, Mansour L, Ahmad M, et al. Study of protein C, protein S, and antithrombin III in neonatal sepsis. Pediatr Crit Care Med. 2010;11(6):624–631.
Han YJ, Park JD, Choi JW, et al. Coagulopathy as a prognostic factor of acute lung injury in children. J Korean Med Sci. 2012;27(12):1541–1546.
Keller K, et al. Pathophysiological relevance of inflammation-coagulation crosstalk in acute lung injury. Int J Mol Sci. 2022;23(18):10245.
Lee SA, Kim H, et al. Clinical outcomes of antithrombin III supplementation in ECMO population: implications for coagulation balance. Ann Palliat Med. 2024;13(1):33–40.
Leviton A, et al. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res. 2004;55(3):355–362.
Li T, et al. Evaluation of variation in coagulation among children with Mycoplasma pneumoniae pneumonia: a case-control study. J Med Case Rep. 2017;11:229.
Li Y, Zhang J, Wang MZ, et al. Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for severity. Ital J Pediatr. 2023;49:156.
Liu X, et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19 pneumonia. Acta Pharm Sin B. 2020;10(7):1224–1234.
Mohamed SA, Elmeazawy R, El Sharaby R, et al. Diagnostic and prognostic value of heparin-binding protein (HBP) in pediatric community-acquired pneumonia. Egypt Pediatr Assoc Gazette. 2024;72:82.
Peng L, et al. Low-dose heparin sodium as a protective factor against bronchiolitis obliterans after adenovirus pneumonia in children. Pediatr Pulmonol. 2024;59(2):265–273.
Ramli NN, et al. Haemostasis and inflammatory parameters as potential biomarkers of venous thromboembolism in trauma patients. Diagnostics (Basel). 2023;13(1):150.
Shrestha BK, et al. Pulmonary hemorrhage in newborns. StatPearls [Internet]. 2025 Jan–. Treasure Island (FL): StatPearls Publishing.
Sokou R, et al. Neonatal hemostasis and the role of antithrombin III in coagulation balance. Diagnostics (Basel). 2022;12(2):261.
Sokou R, et al. Thromboelastometry assessment of coagulopathy in neonates with sepsis and perinatal hypoxia. Front Pediatr. 2023;11:11490207.
Sokou R, Gialamprinou D, Konstantinidi A, et al. Thromboelastometry-based profiling of haemostatic disorders in neonates with sepsis and hypoxia. Antibiotics (Basel). 2025;14(1):101.
Song J, et al. Fibrinogen and D-dimer as biomarkers for inflammation severity in pediatric pneumonia. Front Med (Lausanne). 2024;11:1458211.
Song J, Zhang H, Cheng Y, et al. Clinical value of coagulation function indicators in children with severe pneumonia. Int J Gen Med. 2024;17:4662–4665.
Tsaousi M, et al. Perinatal hypoxia and neonatal coagulation imbalance: a systematic review. Semin Thromb Hemost. 2024;50(4):329–340.
Tsaousi M, Papakyriakou P, Sokou R, et al. Hemostatic status of neonates with perinatal hypoxia: viscoelastic evidence and knowledge gaps. Children (Basel). 2024;11(5):553.
Tsaousi M, Sokou R, et al. Viscoelastic assessment of neonatal hemostasis: implications for hypoxia and infection. Thromb Res. 2023;228:85–92.
Wątroba SJ, Bryda JR. Thromboembolic complications in newborns – diagnostic value of D-dimers concentration. J Pre Clin Clin Res. 2022;16(2):65–70.
Wiedermann CJ, et al. Lessons learned from COVID-19-associated coagulopathy and sepsis. Int J Mol Sci. 2022;23(21):12286.
Xiang M, Wang P, et al. Impact of platelets on pulmonary microcirculation and lung injury. Front Immunol. 2022;13:955654.
Xu J, et al. Dynamic changes in coagulation and fibrinolysis markers in pneumonia. Aging (Albany NY). 2021;13(10):13567–13579.
Xu J, Zhang Y, Li Y, et al. Dynamic changes in coagulation function in patients with pneumonia. Front Med (Lausanne). 2021;8:626384.
Yalaki Z, Alioglu B, Ciftci N, Arikan FI. Evaluation of anticoagulant proteins and fibrinolytic system markers in children with pneumonia. J Pediatr Res. 2019;6(1):24–28.
Zhang Y, Li H, Wu X, et al. Clinical significance of interferon-γ and D-dimer in severe pneumonia. Medicine (Baltimore). 2024;103:e...
Zheng Y, Zhang Y, Huang J, et al. The level of D-dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children. Front Pediatr. 2021;9:676545.
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.